Table 1.
The clinical characteristics of the studied population.
| Characteristics | Case | Control | P |
|---|---|---|---|
| Number of subjects | 105 | 103 | − |
| Age (years) | 56.8 ± 18.3 | 54.0 ± 15.0 | 0.228 |
| Gender (male %) | 55 (52.4%) | 56 (54.4%) | 0.774 |
| Hypertension (%) | 36 (34.0%) | 20 (19.4%) | 0.019 |
| Diabetes (%) | 11 (10.5%) | 9 (8.74%) | 0.815 |
| Heart disease (%) | 18 (17.1%) | 10 (9.71%) | 0.155 |
| Tumor (%) | 5 (4.76%) | 6 (5.83%) | 0.767 |
| Liver disease (%) | 3 (2.86%) | 0 (0.00%) | 0.246 |
| Kidney disease (%) | 9 (8.57%) | 2 (1.94%) | 0.06 |
| White blood cell count (10∧9/L) | 6.94 ± 3.66 | 6.27 ± 1.75 | 0.091 |
| Lymphocyte count (10∧9/L) | 0.81 ± 0.47 | 1.64 ± 0.49 | <0.001 |
| Neutrophil ratio (%) | 76.8 ± 13.6 | 62.3 ± 10.1 | <0.001 |
| Lymphocyte ratio (%) | 14.4 ± 10.5 | 27.6 ± 9.37 | <0.001 |
The data are presented as the mean ± standard deviation or a percentage.